SFM
ASND icon

Sphera Funds Management’s Ascendis Pharma A/S ASND Stock Holding History

Sphera Funds Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,000
Closed -$1.83M – 109
2026
Q1 		$1.83M Sell
8,000
-3,000
-27% -$673K 0.29% 80
2025
Q4 		$2.35M Buy
+11,000
New +$2.27M 0.45% 70
2022
Q2 		– Sell
-26,529
Closed -$3.11M – 60
2022
Q1 		$3.11M Buy
+26,529
New +$3.07M 0.44% 49
2021
Q1 		– Sell
-23,599
Closed -$3.94M – 174
2020
Q4 		$3.94M Sell
23,599
-9,000
-28% -$1.49M 0.35% 77
2020
Q3 		$5.03M Sell
32,599
-1,774
-5% -$255K 0.49% 61
2020
Q2 		$5.08M Buy
34,373
+1,800
+6% +$247K 0.48% 53
2020
Q1 		$3.67M Sell
32,573
-41,200
-56% -$5.35M 0.46% 43
2019
Q4 		$10.3M Hold
73,773
– – 0.85% 20
2019
Q3 		$7.11M Hold
73,773
– – 1.1% 24
2019
Q2 		$8.49M Buy
73,773
+5,500
+8% +$658K 1.16% 23
2019
Q1 		$8.04M Buy
68,273
+10,000
+17% +$876K 0.73% 26
2018
Q4 		$3.65M Sell
58,273
-34,400
-37% -$2.16M 0.41% 54
2018
Q3 		$6.57M Buy
92,673
+14,625
+19% +$1.01M 0.75% 31
2018
Q2 		$5.19M Sell
78,048
-17,426
-18% -$1.15M 0.72% 39
2018
Q1 		$6.24M Sell
95,474
-34,000
-26% -$1.91M 0.95% 32
2017
Q4 		$5.19M Hold
129,474
– – 0.61% 36
2017
Q3 		$4.69M Sell
129,474
-32,143
-20% -$922K 0.67% 42
2017
Q2 		$4.49M Sell
161,617
-93,838
-37% -$2.48M 0.76% 36
2017
Q1 		$7.15M Sell
255,455
-71,167
-22% -$1.8M 1.4% 14
2016
Q4 		$6.61M Buy
326,622
+63,122
+24% +$1.26M 1.67% 14
2016
Q3 		$5.3M Buy
263,500
+1,700
+0.6% +$28.1K 0.86% 26
2016
Q2 		$3.47M Buy
+261,800
New +$4.03M 0.9% 34
2015
Q2 		– Sell
-70,000
Closed -$1.22M – 133
2015
Q1 		$1.22M Buy
+70,000
New +$1.27M 0.13% 128

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sphera Funds Management's ASND Position: Q2 2026 in Review

Sphera Funds Management sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 8,000 shares — an estimated $1.83M sold.

Sphera Funds Management first reported a position in ASND in Q1 2015 and held it in 23 quarters. The position peaked at $10.3M in Q4 2019. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Sphera Funds Management reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
  • Sphera Funds Management sold 8,000 Ascendis Pharma A/S shares in Q2 2026, an estimated $1.83M.
  • Sphera Funds Management first reported a position in Ascendis Pharma A/S in Q1 2015 and held it in 23 quarters.
  • Sphera Funds Management's Ascendis Pharma A/S position peaked at $10.3M in Q4 2019.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.